Yeunjung Kim, MD
Interventional Cardiology · Dalton, GANPI 1881936037
Payments from drug & device makers
Across 747 payments — averaging $143.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$68K
- Edwards Lifesciences$18K
- Abbott$5K
- Angiodynamics, Inc.$4K
- Shockwave Medical, Inc$2K
- Medtronic$2K
- plus $8K from 35 others
Across 1 payment — averaging $108.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$108
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 60 | $68,323 |
| Edwards Lifesciences | 292 | $17,752 |
| Abbott | 54 | $5,364 |
| Angiodynamics, Inc. | 21 | $3,966 |
| Shockwave Medical, Inc | 25 | $1,902 |
| Medtronic(2 entities) | 24 | $1,532 |
| Abiomed | 19 | $1,387 |
| Johnson & Johnson | 57 | $1,131 |
| Philips North America LLC | 15 | $909 |
| Novartis | 46 | $744 |
| Teleflex LLC | 8 | $354 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $318 |
| Amgen | 12 | $312 |
| Novo Nordisk | 14 | $283 |
| Merck | 14 | $269 |
| Terumo Medical Corporation | 2 | $250 |
| Cardiovascular Systems Inc. | 7 | $245 |
| Bayer | 7 | $239 |
| AstraZeneca | 14 | $234 |
| Heartflow, Inc. | 3 | $228 |
| Cardinal Health 200 LLC | 3 | $209 |
| Inari Medical, Inc. | 1 | $199 |
| Spectrawave, Inc | 1 | $106 |
| Recor Medical Inc | 1 | $105 |
| Astellas Pharma US Inc | 1 | $100 |
| Biosense Webster, Inc. | 1 | $94 |
| Cardiva Medical, Inc. | 4 | $84 |
| Pfizer | 4 | $81 |
| Esperion Therapeutics, Inc. | 3 | $62 |
| Cvrx, Inc. | 2 | $49 |
| Irhythm Technologies, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Siemens Medical Solutions USA, Inc. | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Medicomp Inc | 1 | $20 |
| Cordis US CORP. | 1 | $20 |
| Stryker | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $11 |
How this compares
$107,127 in reported general payments places this provider in the 80th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Dalton
- Ahsan AchtchiDalton$121K
- Eric GuerraDalton$35K
- David KandzariAtlanta$3.7M
- Pradeep YadavAtlanta$3.5M
- Vasilis BabaliarosAtlanta$2.7M
- Megan CoylewrightCalhoun$2.3M
- William NicholsonAtlanta$2M
- Chandanreddy DevireddyAtlanta$1.9M
- Adam GreenbaumAtlanta$1.8M
- Amar PatelMarietta$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.